Posted by Michael Wonder on 18 May 2023
NICE draft guidance recommends new treatment for chronic heart failure
18 May 2023 - Up to 150,000 people in England with a type of chronic heart failure are set to benefit from a new treatment following its approval by NICE.
NICE has today issued final draft guidance which recommends dapagliflozin (Forxiga, AstraZeneca) as an option for adults with symptomatic chronic heart failure with preserved or mildly reduced ejection fraction.
